Peers
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for JNJ (Johnson & Johnson) from 1990 to Jan 24 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Johnson & Johnson stock (JNJ) PE ratio as of Jan 24 2022 is 24.09. More Details

Johnson & Johnson PE Ratio (TTM) Chart

EMBED

Johnson & Johnson PE Ratio (TTM) Historical Data

Total 1223
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Johnson & Johnson PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2022-01-2424.1 2021-11-2223.9
2022-01-2124.6 2021-11-1924.4
2022-01-2024.7 2021-11-1824.3
2022-01-1924.9 2021-11-1724.4
2022-01-1825.0 2021-11-1624.3
2022-01-1725.1 2021-11-1524.4
2022-01-1425.1 2021-11-1224.7
2022-01-1325.2 2021-11-1124.4
2022-01-1225.4 2021-11-1024.6
2022-01-1125.6 2021-11-0924.3
2022-01-1025.9 2021-11-0824.4
2022-01-0726.0 2021-11-0524.4
2022-01-0625.7 2021-11-0424.6
2022-01-0525.7 2021-11-0324.7
2022-01-0425.6 2021-11-0224.8
2022-01-0325.6 2021-11-0124.4
2021-12-3125.6 2021-10-2924.4
2021-12-3025.8 2021-10-2824.3
2021-12-2925.6 2021-10-2724.5
2021-12-2825.5 2021-10-2624.8
2021-12-2725.4 2021-10-2524.5
2021-12-2425.2 2021-10-2224.5
2021-12-2325.2 2021-10-2124.4
2021-12-2225.1 2021-10-2024.5
2021-12-2125.0 2021-10-1924.5
2021-12-2025.1 2021-10-1823.9
2021-12-1725.2 2021-10-1524.1
2021-12-1625.9 2021-10-1423.9
2021-12-1525.6 2021-10-1323.8
2021-12-1425.5 2021-10-1223.6
2021-12-1325.2 2021-10-1124.0
2021-12-1024.7 2021-10-0824.1
2021-12-0924.8 2021-10-0724.1
2021-12-0824.6 2021-10-0623.9
2021-12-0724.4 2021-10-0523.9
2021-12-0624.4 2021-10-0423.8
2021-12-0323.8 2021-10-0124.0
2021-12-0223.5 2021-09-3024.1
2021-12-0123.6 2021-09-2924.5
2021-11-3023.3 2021-09-2824.3
2021-11-2923.9 2021-09-2724.5
2021-11-2623.8 2021-09-2424.7
2021-11-2524.0 2021-09-2324.8
2021-11-2424.0 2021-09-2224.7
2021-11-2324.0 2021-09-2124.7

Johnson & Johnson PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Johnson & Johnson logo

Business Description

Industry
Healthcare » Drug Manufacturers » NAICS : 325412 SIC : 2834
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.